Michel Delforge
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 118
- Multiple Myeloma Research and Treatments 95
- Acute Myeloid Leukemia Research 15
-
- Protein Degradation and Inhibitors 38
- Amyloidosis: Diagnosis, Treatment, Outcomes 14
- Co-authors
- Meletios Α. Dimopoulos (25 shared papers)Jesús F. San Miguel (21 shared papers)Michèle Cavo (12 shared papers)Sam Noppen (1 shared paper)Jean Willems (1 shared paper)Eef Parthoens (1 shared paper)Ellen Wirawan (1 shared paper)Riet De Rycke (1 shared paper)
- Journals
- Blood (24 papers)Journal of Clinical Oncology (20 papers)Leukemia (10 papers)British Journal of Haematology (8 papers)Haematologica (4 papers)
- Partner nations
- BelgiumUnited StatesSpain
In The Last Decade
Michel Delforge
147 papers receiving 4.3k citations
Michel Delforge's Hit Papers
Peers
Comparison fields: 5 of 120
- Hematology 2.6k
- Genetics 646
- Oncology 1.6k
- Immunology 846
- Molecular Biology 2.1k
Countries citing papers authored by Michel Delforge
This map shows the geographic impact of Michel Delforge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Delforge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Delforge more than expected).
Fields of papers citing papers by Michel Delforge
This network shows the impact of papers produced by Michel Delforge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Delforge. The network helps show where Michel Delforge may publish in the future.
Co-authors
The 25 scholars most cited alongside Michel Delforge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neutrophil extracellular trap cell death requires both autophagy and superoxide generation Hit paper breakdown → | 2010 | 658 |
| 2 | Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† Hit paper breakdown → | 2021 | 460 |
| 3 | 2016 | 219 | |
| 4 | 2017 | 202 | |
| 5 | 2010 | 157 | |
| 6 | 2018 | 152 | |
| 7 | 2011 | 132 | |
| 8 | 2009 | 119 | |
| 9 | 2003 | 92 | |
| 10 | 2011 | 88 | |
| 11 | 2017 | 84 | |
| 12 | 2021 | 84 | |
| 13 | 2010 | 81 | |
| 14 | 2014 | 80 | |
| 15 | 2018 | 78 | |
| 16 | 2016 | 77 | |
| 17 | 2014 | 65 | |
| 18 | 2002 | 62 | |
| 19 | 2019 | 58 | |
| 20 | 2012 | 56 |
About Michel Delforge
Michel Delforge is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Immunology, having authored 150 papers that have together received 4.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (95 papers), Protein Degradation and Inhibitors (38 papers), Cancer Treatment and Pharmacology (30 papers), Acute Myeloid Leukemia Research (15 papers), CAR-T cell therapy research (15 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Peptidase Inhibition and Analysis (12 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (646 citations), Oncology (1.6k citations), Immunology (846 citations) and Molecular Biology (2.1k citations). Michel Delforge has collaborated with scholars based in Belgium, United States and Spain. Frequent co-authors include Meletios Α. Dimopoulos, Jesús F. San Miguel, Michèle Cavo, Sam Noppen, Jean Willems, Eef Parthoens, Ellen Wirawan, Riet De Rycke, Bob Asselbergh and Quinten Remijsen. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, British Journal of Haematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.